Inlet Private Wealth LLC grew its position in UnitedHealth Group Inc (NYSE:UNH) by 23.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,067 shares of the healthcare conglomerate’s stock after buying an additional 200 shares during the quarter. Inlet Private Wealth LLC’s holdings in UnitedHealth Group were worth $232,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Garrison Point Advisors LLC boosted its stake in UnitedHealth Group by 1.2% in the 2nd quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock worth $851,000 after buying an additional 40 shares during the last quarter. Smith Moore & CO. boosted its stake in UnitedHealth Group by 1.3% in the 2nd quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock worth $770,000 after buying an additional 41 shares during the last quarter. Integrated Investment Consultants LLC boosted its stake in UnitedHealth Group by 3.9% in the 2nd quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 42 shares during the last quarter. Meridian Financial Partners LLC boosted its stake in UnitedHealth Group by 2.7% in the 2nd quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock worth $403,000 after buying an additional 43 shares during the last quarter. Finally, 1ST Source Bank boosted its stake in UnitedHealth Group by 3.0% in the 2nd quarter. 1ST Source Bank now owns 1,569 shares of the healthcare conglomerate’s stock worth $383,000 after buying an additional 45 shares during the last quarter. Institutional investors and hedge funds own 85.71% of the company’s stock.
UnitedHealth Group stock traded up $2.69 during midday trading on Friday, hitting $243.50. 887,204 shares of the company were exchanged, compared to its average volume of 5,304,409. The company’s fifty day moving average price is $227.10 and its 200-day moving average price is $239.65. The company has a market cap of $226.11 billion, a PE ratio of 18.91, a price-to-earnings-growth ratio of 1.26 and a beta of 0.60. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.67. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.77%. The ex-dividend date was Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 2,000 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were bought at an average cost of $227.55 per share, for a total transaction of $455,100.00. Following the acquisition, the director now directly owns 5,524 shares of the company’s stock, valued at $1,256,986.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $233.40, for a total value of $583,500.00. Following the sale, the director now owns 187,979 shares in the company, valued at $43,874,298.60. The disclosure for this sale can be found here. Insiders have sold a total of 24,000 shares of company stock worth $5,924,120 over the last three months. 0.87% of the stock is currently owned by corporate insiders.
UNH has been the topic of a number of research analyst reports. BMO Capital Markets lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $292.00 to $249.00 in a research note on Monday, September 30th. Cantor Fitzgerald set a $310.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday. Morgan Stanley reduced their price objective on UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective on the stock in a research note on Monday, July 22nd. Finally, Barclays set a $260.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a research note on Tuesday, October 8th. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $283.84.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Range Trading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.